11^th World Glycobiology Congress

Instructor in the Basic Biochemistry course for Biology, Nursing, Veterinary and Agronomy students, UESC, Brazil, 2006. Instructor in the Cellular Biology course for Biology students, UESC, Brazil, 2007. "Techniques for Diagnoses of Intestinal Parasites", UESC, Brazil, 2007 (instructor of a short term course) Instructor in the Medical Bacteriology course for Biomedicine students, UESC, Brazil, 2007. Lecturer in Pathology course for Biomedicine and Pharmacy, UFMG, Brazil, 2016-present

Molecular Biotechnology, Stem Cell Research

I am Dr. Mojtaba Mafi M.D., Medical Doctor/ Physician, graduated from Tehran University, School of Medicine with honor. I studied in neurosurgery ward and graduated with A score with thesis on Meningioma Brain Tumor during 6 years. With continuing my practice with special consideration on psychosomatic disorders, I completed many postgraduate courses on health psychology, addiction medicine, sexual disorders therapy successfully. I passed many postgraduate courses in Neuro, approved by Medical sciences university. As well, I have been passed postgraduate courses on Nutrition, Gastroenterology and Hepatology, Obesity treatment and diabetes approved by Tehran University of Medical Sciences. I successfully passed more than 10 programs with certificates and membership in the Iranian Association of Gastroenterology and Hepatology. Having honor of working as an associate of Iran Hepatitis Network and Gastroenterology and The hepatology research center, Middle East Liver Diseases Center (MELD). This strong study background enabled me to successfully earn certificates on 3 programs: Updates of skin and treatment from Tehran university 2015 and course on skin care updates from Iranian society of practitioners in 2016, and during 2 years, I had passed Beauty and Skincare courses in South Korea and certified from Sunghuwan co Ltd for using and working of beauty technology, RF and IPL. I am director of fatty liver and related metabolic disorders study among Iranian families since 2015 and currently publishing the results of our study and research about fatty liver and hyperlipidemia, diabetes and nutrition as study director and clinician associate member of Iran Hepatitis Network. I am a reviewer and associate editor of Hepatitis Monthly Journal and reviewer of Journal of Clinical and Translational Hepatology. I am an editorial board member of International Journal of Psychology and Neurosciences.

Neurosurgery, Gastroenterology and Hepatology

Thirty nine years of the teaching and researching experience. She is the Director of Research Group HUM113-Estudios Filológicos from Program of Research of Andalusian Government, where she has managed and directed several academic and scientific contracts and research projects, as well as a Member of Athens Institute for Education & Research (ATINER) in Greece, The Academic Genesis Platform (UAGP) in UK&Turkey and Experts of Academic Excellence Research Centre (EAERC) in Jordan; etc. She is author of a many works on several aspects of the Arabic science and literature in the Middle Ages, as well as Arabic language and linguistics. She has also participated in different prestigious international scientific Conferences. She has visited a many universities and academic institutions of Europe, United States and Arab countries in order to teach and research. Among her works, we have the study and the translation to Spanish of some treatises of Kitab al-tasrif´s Al-Zahrawi, Ibn Qutayba´s texts, Maqamas of Al-Hariri, The Sicilian Questions of Ibn Sab´in, etcetera.

Medieval Arabic Science. Humanities. Arabic Philology

Segundo Mesa Castillo. As Specialist in Neurology, he worked for 10 years in the Institute of Neurology of Havana, Cuba. He has worked in Electron Microscopic Studies on Schizophrenia for 32 years. He was awarded with the International Price of the Stanley Foundation Award Program and for the Professional Committee to work as a fellowship position in the Laboratory of the Central Nervous System Studies, National Institute of Neurological Diseases and Stroke under Dr. Joseph Gibbs for a period of 6 months, National Institute of Health, Bethesda, Maryland, Washington D.C. USA, June 5, 1990. At present, he is a member of the Scientific Board of the Psychiatric Hospital of Havana and gives lectures to residents in psychiatry.

Specialist in Neurology

Dr Srivastava has an impressive track record of more than 10 years as an academician as well as has a strong experience of working in Biotechnology industries (10 years) prior to joining academics. He has been visiting Scholar to University of Sydney. He has served as Visiting Professor at University of Pune (2001-2003), Indian Institute of Management (Lucknow) and several other Institutes. He is also a Scientific Expert in Chemistry and Chemical Sciences at Indian Patent Office. He has advised several PhD( 06 Awarded), 30 MTech, and 06 MS(Master of Surgery & Medicine) Thesis and one Post Doc fellow. His research activities have resulted in more than 80 peer reviewed International / National Publications/ Proceedings, 01 Book and 08 Book Chapters, 06 Patents and over 100 presentations at Conferences, including 40 Invited Lectures. In addition to his publication activities, He is in Editorial Board of Several National and International Journals. . Dr Srivastava has been recipient of several Awards and Honours, including ORS Award of UK, DBT Overseas Associateship(GOI),CSIR Post DOC Award, Member National Academy of Sciences, etc. He is also member of several Professional Societies like AAPS, TERMIS, IIChe, etc. Dr Srivastava, has been serving the Society by playing a pivotal role in Entrepreneurship. He has initiated Centers for Entrepreneurial Learning(OLPE), Technology Entrepreneurship Promotion Program(Funded by DSIR, GOI), Technology Commercialization Facilitation Program(TCFA, TIFAC), Innovation Cluster in SME, and establishment of Technology Business Incubator at IIT(BHU) Varanasi, to promote Start UP activities in Innovative Technologies. He is mentor to 03 startup companies on innovative technologies. He has been Technical Advisor to several Companies to include Nanyang Pukang Group (China), Alkem Ltd, TRCC Gurgaon, Varuna BioCell(P) Ltd, Amrutanjun, Ltd, FICCI, Observing Eye , Agati HealthCare (P) Ltd, etc. His expertise in Technology Transfer and IPR is well acclaimed by his significant contribution in several committees at Institute/ University level, Government level, etc.

Health care derivatives/products and process development, evaluation and development of Platform technologies in Translational Health Sciences which include Stem Cell regeneration, Wound Healing Process, Cancer research, and acute kidney failure in children.

Sergey Suchkov graduated from Astrakhan State Medical University and awarded with MD, then in 1985 maintained his PhD at the I.M. Sechenov Moscow Medical Academy and in 2001, maintained his Doctorship Degree at the Nat Inst of Immunology, Russia. From 1987 through 1989, he was a senior Researcher, Koltzov Inst of Developmental Biology. From 1989 through 1995, he was a Head of the Lab of Clinical Immunology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004, a Chair of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI. Dr Suchkov has been trained at: NIH; Wills Eye Hospital, PA, USA; Univ of Florida in Gainesville; UCSF, S-F, CA, USA; Johns Hopkins University, Baltimore, MD, USA. He was an Exe Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov is a Chair, Dept for Personalized and Translational Medicine, I.M.Sechenov First Moscow State Medical University. He is a member of the: New York Academy of Sciences, USA; American Chemical Society (ACS), USA; American Heart Association (AHA), USA; EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU; ARVO (American Association for Research in Vision and Ophthalmology); ISER (International Society for Eye Research); PMC (Personalized Medicine Coalition), Washington, USA.

Sergey Suchkov research interests include the area of mechanisms of chronization, intertalks between innate and adaptive immunity, and interdisciplinary.

Myron R Szewczuk has completed his PhD in 1974 from University of Windsor in Biology and Immunochemistry and Postdoctoral studies from Cornell University Medical College, New York City, USA in Cellular Immunology with Dr Greg Siskind (1975-1978). He is presently a Full Professor of Immunology and Associate Professor of Medicine, Queen’s University, Canada. He has published more than 100 papers in reputed journals and has been serving as an editorial Board Member of repute.

His research interest includes the alternate therapeutic treatment of cancer and the role of glycosylation in the activation of neurotrophin Trk, EGFR, insulin and TOLL-like receptors.

Dr. Menter received his PhD degree in Chemistry from the George Washington University in 1969. He completed a postdoctoral fellowship with Prof. Dr. Theodor Foerster at the Institut fuer physikalische Chemie der Universtiaet Stuttgart, Germany. Subsequently, he was at the University of Alabama, Birmingham, and the VA Medical Center (Atlanta) He currently serves as Research Professor of Biochemistry at Morehouse School of Medicine. Dr. Menter is recognized internationally for his work in the areas of collagen photochemistry and melanin photobiology as pertaining to redox reactivity.

His research interest includes in the areas of collagen photochemistry and melanin photobiology as pertaining to redox reactivity.

Robert Engel is Professor of Chemistry and Biochemistry at Queens College and has been in that position since 1968. He has also served there as Dean of Graduate Studies and Research and Dean of Mathematics and the Natural Sciences.

Cyclodextrins

Amélia Pilar Rauter has made her Habilitation at Faculty of Sciences, University of Lisbon (FCUL, 2002) and completed her PhD at Technische Universitaet Graz, Austria (1982). She is the Head of the Carbohydrate Chemistry Group - Center of Chemistry and Biochemistry (FCUL), and has been serving as Editor (RSC Carbohydrate Chemistry book series), Associated Editor (Mediterranean Journal of Chemistry), and member of journals advisory board in Organic/Carbohydrate Chemistry. She is Secretary of the European Carbohydrate Organisation and Secretary of the IUPAC Division on Organic and Biomolecular Chemistry, has published more than 130 papers and book chapters, and authored 12 patents.

Her research interest includes promising molecules for metabolic (diabetes), degenerative diseases (Alzheimer´s and Prion diseases, cancer) and infection.

Jorge Justino has his expertise in the biological evaluation and toxicity studies of natural and synthetic compounds and food chemistry. Full Professor of Escola Superior Agrária de Santarém, MSc. and Ph.D in Chemical Engineering at Instituto Superior Técnico – Universidade Técnica de Lisboa, Habilitation in Food Chemistry at Universidade de Trás-Os-Montes e Alto Douro. He is President of Instituto Politécnico de Santarém and former Director of Escola Superior Agrária de Santarém, He was a member of the networks Euroglycoforum and Prion Chemical Biology Network and is the representative member of the Instituto Politécnico de Santarém at the European Innovation Partnership A3 Group FCUL consortium.

Expertise in the biological evaluation and toxicity studies of natural and synthetic compounds and food chemistry.

Robert Engel is Professor of Chemistry and Biochemistry at Queens College and has been in that position since 1968. He has also served there as Dean of Graduate Studies and Research and Dean of Mathematics and the Natural Sciences.

Cyclodextrins

Jorge Justino has his expertise in the biological evaluation and toxicity studies of natural and synthetic compounds and food chemistry. Full Professor of Escola Superior Agrária de Santarém, MSc. and Ph.D in Chemical Engineering at Instituto Superior Técnico – Universidade Técnica de Lisboa, Habilitation in Food Chemistry at Universidade de Trás-Os-Montes e Alto Douro. He is President of Instituto Politécnico de Santarém and former Director of Escola Superior Agrária de Santarém, He was a member of the networks Euroglycoforum and Prion Chemical Biology Network and is the representative member of the Instituto Politécnico de Santarém at the European Innovation Partnership A3 Group FCUL consortium.

Expertise in the biological evaluation and toxicity studies of natural and synthetic compounds and food chemistry.

Myron R Szewczuk has completed his PhD in 1974 from University of Windsor in Biology and Immunochemistry and Postdoctoral studies from Cornell University Medical College, New York City, USA in Cellular Immunology with Dr Greg Siskind (1975-1978). He is presently a Full Professor of Immunology and Associate Professor of Medicine, Queen’s University, Canada. He has published more than 100 papers in reputed journals and has been serving as an editorial Board Member of repute.

His research interest includes the alternate therapeutic treatment of cancer and the role of glycosylation in the activation of neurotrophin Trk, EGFR, insulin and TOLL-like receptors.

Dr. Menter received his PhD degree in Chemistry from the George Washington University in 1969. He completed a postdoctoral fellowship with Prof. Dr. Theodor Foerster at the Institut fuer physikalische Chemie der Universtiaet Stuttgart, Germany. Subsequently, he was at the University of Alabama, Birmingham, and the VA Medical Center (Atlanta) He currently serves as Research Professor of Biochemistry at Morehouse School of Medicine. Dr. Menter is recognized internationally for his work in the areas of collagen photochemistry and melanin photobiology as pertaining to redox reactivity.

His research interest includes in the areas of collagen photochemistry and melanin photobiology as pertaining to redox reactivity.

Amélia Pilar Rauter has made her Habilitation at Faculty of Sciences, University of Lisbon (FCUL, 2002) and completed her PhD at Technische Universitaet Graz, Austria (1982). She is the Head of the Carbohydrate Chemistry Group - Center of Chemistry and Biochemistry (FCUL), and has been serving as Editor (RSC Carbohydrate Chemistry book series), Associated Editor (Mediterranean Journal of Chemistry), and member of journals advisory board in Organic/Carbohydrate Chemistry. She is Secretary of the European Carbohydrate Organisation and Secretary of the IUPAC Division on Organic and Biomolecular Chemistry, has published more than 130 papers and book chapters, and authored 12 patents.

Her research interest includes promising molecules for metabolic (diabetes), degenerative diseases (Alzheimer´s and Prion diseases, cancer) and infection.

Neil Price has a PhD from the University of London, and has postdoctoral experience at the Univ. of Geneva in Switzerland, Paul-Sabatier University in Toulouse, and the Complex Carbohydrate Research Center in Athens, GA. He held a faculty position the U. of Rochester, NY before moving to the NCAUR, Peoria.

His research includes carbohydrate chemistry and biochemistry, mass spectrometry, and microbial metabolism. He currently serves on the ARS National Chemical Patent committee, and has over 90 peer-reviewed research publications.

Dr. Menter received his PhD degree in Chemistry from the George Washington University in 1969. He completed a postdoctoral fellowship with Prof. Dr. Theodor Foerster at the Institut fuer physikalische Chemie der Universtiaet Stuttgart, Germany. Subsequently, he was at the University of Alabama, Birmingham, and the VA Medical Center (Atlanta) He currently serves as Research Professor of Biochemistry at Morehouse School of Medicine. Dr. Menter is recognized internationally for his work in the areas of collagen photochemistry and melanin photobiology as pertaining to redox reactivity.

His research interest includes in the areas of collagen photochemistry and melanin photobiology as pertaining to redox reactivity.

Professor Marzabadi completed her PhD at the University of Missouri – St. Louis and carried out postdoctoral studies at Hunter College- CUNY. She has been at Seton Hall University for the past 15 years and has been a Visiting Professor at Harvard University Medical School and a Visiting Researcher at Memorial Sloan Kettering Cancer Center. She has published numerous papers in the carbohydrate literature and currently serves as a Member at Large for the ACS Division of Carbohydrate Chemistry.

Her research interest includes the synthesis and biological evaluation of new carbohydrate structures with the capacity to act as immunomodulators.

Maria Longas completed her PhD at New York University in 1978, and did her postdoctoral training at Columbia University School of Medicine with Dr. Karl Mayer. She has an MA in Organic Chemistry from New York University (1973) and a BA in Chemistry from Hunter College (1971). She is a full Professor of Chemistry at Purdue University Calumet in Hammond, IN. She has more than 24 papers published in reputable journals, and served as a reviewer for several journals.

Her research interest includes arthritis, tuberculosis and autoimmune disorders.

Michael Strano is currently the Carbon P. Dubbs Professor of Chemical Engineering at MIT. He received his B.S from Polytechnic University in Brooklyn, NY and Ph.D. from the University of Delaware, both in Chemical Engineering. He was a post doctoral research fellow at Rice University in the departments of Chemistry and Physics under the guidance of Nobel Laureate Richard E. Smalley. From 2003 to 2007, Michael was an Assistant Professor in the Department of Chemical and Biomolecular Engineering at the University of Illinois at Urbana-Champaign before moving to MIT.

His research focuses on biomolecule/nanoparticle interactions and the surface chemistry of low dimensional systems, nano-electronics, nanoparticle separations, and applications of vibrational spectroscopy to nanotechnology.

Peter Quinn is the Emeritus Professor of Biochemistry at King’s College London. His research interests are the structure and properties of biological membranes. He has published more than 500 research papers and reviews of the subject. The experimental approach has been to investigate the structure and molecular arrangement of the different lipids and proteins using a variety of biophysical methods and more recently all atomistic molecular dynamic simulations. The role and arrangement of glycosphingolipids in membranes has been a particular challenge.

His research interests are the structure and properties of biological membranes

Jorge Justino has his expertise in the biological evaluation and toxicity studies of natural and synthetic compounds and food chemistry. Full Professor of Escola Superior Agrária de Santarém, MSc. and Ph.D in Chemical Engineering at Instituto Superior Técnico – Universidade Técnica de Lisboa, Habilitation in Food Chemistry at Universidade de Trás-Os-Montes e Alto Douro. He is President of Instituto Politécnico de Santarém and former Director of Escola Superior Agrária de Santarém, He was a member of the networks Euroglycoforum and Prion Chemical Biology Network and is the representative member of the Instituto Politécnico de Santarém at the European Innovation Partnership A3 Group FCUL consortium.

Expertise in the biological evaluation and toxicity studies of natural and synthetic compounds and food chemistry.

Myron R Szewczuk has completed his PhD in 1974 from University of Windsor in Biology and Immunochemistry and Postdoctoral studies from Cornell University Medical College, New York City, USA in Cellular Immunology with Dr Greg Siskind (1975-1978). He is presently a Full Professor of Immunology and Associate Professor of Medicine, Queen’s University, Canada. He has published more than 100 papers in reputed journals and has been serving as an editorial Board Member of repute.

His research interest includes the alternate therapeutic treatment of cancer and the role of glycosylation in the activation of neurotrophin Trk, EGFR, insulin and TOLL-like receptors.

András Guttman, MTA-PE Lendulet professor of Translational Glycomics, directs the Horváth Csaba Laboratory of Bioseparation Sciences in Hungary and leads the application efforts in Sciex in California. His work is focused on capillary electrophoresis and CESI-MS based glycomics and glycoproteomics analysis of biomedical, cell biology and biopharmaceutical, interests. Professor Guttman has close to 300 scientific publications, wrote 35 book chapters, edited 4 textbooks and holds 23 patents. He is on the board of several international organizations, on the editorial boards of a dozen scientific journals, has been recognized by numerous awards and member of the Hungarian Academy of Sciences.

His research interests include the glycomics and glycoproteomics analysis of biomedical, cell biology and biopharmaceutical development.

Amélia Pilar Rauter has made her Habilitation at Faculty of Sciences, University of Lisbon (FCUL, 2002) and completed her PhD at Technische Universitaet Graz, Austria (1982). She is the Head of the Carbohydrate Chemistry Group - Center of Chemistry and Biochemistry (FCUL), and has been serving as Editor (RSC Carbohydrate Chemistry book series), Associated Editor (Mediterranean Journal of Chemistry), and member of journals advisory board in Organic/Carbohydrate Chemistry. She is Secretary of the European Carbohydrate Organisation and Secretary of the IUPAC Division on Organic and Biomolecular Chemistry, has published more than 130 papers and book chapters, and authored 12 patents.

Her research interest includes promising molecules for metabolic (diabetes), degenerative diseases (Alzheimer´s and Prion diseases, cancer) and infection.

Ulrich Zähringer obtained his PhD degree in 1979 with H Grisebach, Biochemistry of Plants, Freiburg University, Germany. In 1981 he moved with Prof. Ernst T Rietschel, Director at the Research Center Borstel, where he obtained a tenure position as head of the Division of Immunochemistry. He made three postdoctoral trainings: i) 1980-1981 in O Lüderitz’s Lab at the Max-Planck-Institute for Immunobiology, Freiburg; ii) 1983-1984 at T Shiba’s and S Kusumoto’s Lab, University of Osaka, Faculty of Sciences, Osaka, Japan, and iii) during 2004-2005 with S Grzesiek, NMR Structural Biology at the Biozentrum in Basel, Switzerland. In 1996 he finished his habilitation and promoted in 2002 as extraordinary Professor at the University of Lübeck till his retirement in 2012. He published more than 250 papers in peer-reviews journals and 55 reviews.

His major interests are the analysis of structure-function relationship of pro-inflammatory bacterial compounds, such as lipopolysaccharide (LPS), oligosaccharides, lipopeptides, lipoteichoic acids (LTA) and peptidoglycan (PGN).

Neil Price has a Ph.D. from the University of London, and has postdoctoral experience at the Univ. of Geneva in Switzerland, Paul-Sabatier University in Toulouse, and the Complex Carbohydrate Research Center in Athens, GA. He held a faculty position the U. of Rochester, NY before moving to the NCAUR, Peoria.

His research includes carbohydrate chemistry and biochemistry, mass spectrometry, and microbial metabolism. He currently serves on the ARS National Chemical Patent committee, and has over 90 peer-reviewed research publications.

Dr. Menter received his Ph.D. degree in Chemistry from the George Washington University in 1969. He completed a postdoctoral fellowship with Prof. Dr. Theodor Foerster at the Institut fuer physikalische Chemie der Universtiaet Stuttgart, Germany. Subsequently, he was at the University of Alabama, Birmingham, and the VA Medical Center (Atlanta) He currently serves as Research Professor of Biochemistry at Morehouse School of Medicine. Dr. Menter is recognized internationally for his work in the areas of collagen photochemistry and melanin photobiology as pertaining to redox reactivity.

His research interest includes in the areas of collagen photochemistry and melanin photobiology as pertaining to redox reactivity.

Maria Longas completed her PhD at New York University in 1978, and did her postdoctoral training at Columbia University School of Medicine with Dr. Karl Mayer. She has an MA in Organic Chemistry from New York University (1973) and a BA in Chemistry from Hunter College (1971). She is a full Professor of Chemistry at Purdue University Calumet in Hammond, IN. She has more than 24 papers published in reputable journals, and served as a reviewer for several journals.

Her research interest includes arthritis, tuberculosis and autoimmune disorders.

Myron R Szewczuk has completed his PhD in 1974 from University of Windsor in Biology and Immunochemistry and Postdoctoral studies from Cornell University Medical College, New York City, USA in Cellular Immunology with Dr Greg Siskind (1975-1978). He is presently a Full Professor of Immunology and Associate Professor of Medicine, Queen’s University, Canada. He has published more than 100 papers in reputed journals and has been serving as an editorial Board Member of repute.

His research interest includes the alternate therapeutic treatment of cancer and the role of glycosylation in the activation of neurotrophin Trk, EGFR, insulin and TOLL-like receptors.

Professor Marzabadi completed her PhD at the University of Missouri – St. Louis and carried out postdoctoral studies at Hunter College- CUNY. She has been at Seton Hall University for the past 15 years and has been a Visiting Professor at Harvard University Medical School and a Visiting Researcher at Memorial Sloan Kettering Cancer Center. She has published numerous papers in the carbohydrate literature and currently serves as a Member at Large for the ACS Division of Carbohydrate Chemistry.

Her research interest includes the synthesis and biological evaluation of new carbohydrate structures with the capacity to act as immunomodulators.

Dev Arya earned his B.Sc. (chemistry honors program) from St. Stephen's College, Delhi; and Ph.D. (Bioorganic Chemistry) from Northeastern University, Boston. After spending his postdoctoral years in the labs of Prof. T. C. Bruice (UC Santa Barbara), he joined the faculty at Clemson University. Dr. Arya is a recipient of a National Science Foundation CAREER Award (2002) and the ACS Horace S. Isbell Award of the Division of Carbohydrate Chemistry (2007). He has served as the Program Chair (2004-2008), Chair-Elect (2009-2010) and Chair (2010-2011) of the ACS Division of Carbohydrate Chemistry.

His research interest includes the design, and discovery of new motifs for the molecular recognition of biological macromolecules.

JDM has completed his PhD at Carlsberg Laboratory, before he moved to Danisco, now Danisco/Dupont, where he worked 20 years as scientist and Research Manager and finally Director of Research in Danisco Biotechnology. He moved to the Technical University in 2008 with a Danisco grant to establish a group working on enzymes, hydrocolloids and prebiotic oligosaccharides. He has published 138 publications and 25 Patents.

His research interest includes functional glycans and human milk oligosaccharides.

Cheorl-Ho Kim has completed his Ph.D at the age of 28 years from The University of Tokyo and was positioned as a senior scientist from Korea Research Institute of Bioscience and Biotechnology. He is a professor of Molecular Glycobiology, SungKyunKwan University, Korea, leading organization of Korea, which is cooperated with the SamSung Group. He has published more than 341 papers in reputed journals and serving as an editorial board member, executive editor and editor-in chief of the international journals. His work was contributed to the mechanisms of glycan-mediated Hepatis B viral oncogenesis and invasion, sialoglycan-mediated leukemic differentiation and vascular biology. He is being serves as an Editor-in-Chief of Journal of Glycobiology, Editor-in-Chief of Journal of Microbial and Biochemical Technology, Executive Editor of Journal of Glycomics and Lipidomics, Editor of eCAM, Editor of The Peer Journal and Editor of Current Pharmaceutical Biotechnology.

His research work was contributed to the mechanisms of glycan-mediated Hepatis B viral oncogenesis and invasion, sialoglycan-mediated leukemic differentiation and vascular biology.

Dr. Kubick is head of the department “Cell-free Bioproduction” at the Fraunhofer IZI-BB. His laboratory exploits cell-free protein synthesis as a versatile tool for membrane protein and glycoprotein synthesis, as well as chip-based protein synthesis and translational regulation. In collaboration with Qiagen GmbH he developed novel eukaryotic in vitro translation systems. Dr. Kubick is also a lecturer at the Free University of Berlin and the University of Potsdam. He is an affiliate of the Technical University of Berlin and Lecturer at the University of Applied Sciences, Berlin, Germany.

His research interest includes glycoprotein synthesis, as well as chip-based protein synthesis and translational regulation.

Neil Price has a Ph.D. from the University of London, and has postdoctoral experience at the Univ. of Geneva in Switzerland, Paul-Sabatier University in Toulouse, and the Complex Carbohydrate Research Center in Athens, GA. He held a faculty position the U. of Rochester, NY before moving to the NCAUR, Peoria.

His research includes carbohydrate chemistry and biochemistry, mass spectrometry, and microbial metabolism. He currently serves on the ARS National Chemical Patent committee, and has over 90 peer-reviewed research publications.

Dr. Martinez Duncker is 37 years old and born in Mexico City. He earned his MD degree in the Military Medical School in Mexico after which he went to Paris, France to earn his PhD degree in the Ecole Pratique des Hautes Etudes. He is Director of the Cell Dynamics Research Center of the Morelos State Autonomous University in Cuernavaca, Mexico where he leads the Glycobiology and Human Genetics Program. He also is founder and President of the Latin American Society of Glycobiology.

His research includes the identification of novel sialoproteins and sialolipids through this approach sheds light into novel functions of sialic acids during Th activation.

George Bousfield completed his PhD at Indiana University in 1981. He then pursued postdoctoral studies at the University of Texas, M.D. Anderson Cancer Center with Darrell Ward. He is currently the Dr. L.M. Jones Distinguished Professor in the Fairmount College of Liberal Arts and Sciences at Wichita State University, and director of the WSU Protein Core Facility. He has published more than 56 journal articles.

His research interests are follicle-stimulating hormone (FSH) and luteinizing hormone (LH), play central roles in the control of reproduction by connecting neuroendocrine hypothalamic/pituitary activities to gonadal function.

Ying Qing is a Principal Scientist in the Pharmaceutical group at Waters Corporation. She joined Waters Corporation since 2001, shortly after she received her Ph.D. from the Analytical Chemistry Department at Purdue University. She is a group leader in the Biopharmaceutical lab unit at Waters. Her group’s focus is on Protein Biotherapeutics characterization using UPLC/QTOF MS platform. The projects she is currently working on range from glycan profiling, peptide mapping and lately the Hydrogen Deuterium Exchange Mass Spectrometry for protein higher order structure analysis. She has extensive experience in Mass Spectrometry, Gas-Phase Ion Chemistry and Liquid Chromatography Separation Techniques.

Her research interest focus is on Protein Biotherapeutics characterization using UPLC/QTOF MS platform.

Professor Marzabadi completed her PhD at the University of Missouri – St. Louis and carried out postdoctoral studies at Hunter College- CUNY. She has been at Seton Hall University for the past 15 years and has been a Visiting Professor at Harvard University Medical School and a Visiting Researcher at Memorial Sloan Kettering Cancer Center. She has published numerous papers in the carbohydrate literature and currently serves as a Member at Large for the ACS Division of Carbohydrate Chemistry.

Her research interest includes the synthesis and biological evaluation of new carbohydrate structures with the capacity to act as immunomodulators.

Guijun Wang has completed her PhD in 1999 from Michigan State University and postdoctoral research at Yale University in 2002. She started her independent career as an assistant professor at the University of New Orleans in 2002. In 2012, she relocated to Old Dominion University (ODU), currently she is a professor of Chemistry and Biochemistry at ODU.

Her research interests include synthetic methodology development; asymmetric synthesis; and the synthesis and study of carbohydrate based self-assembling systems. She has co-authored 50 peer reviewed papers and is the co-inventor on 20 international and US patents.

Konrad Sandhoff completed his PhD in biochemistry in Munich. After research stays in Munich, Israel and the USA he became a full professor of biochemistry at the University of Bonn in 1979. Since 2007 he is a senior professor at the LIMES institute, Bonn.

Major Research Interests: Molecular life sciences: analysis and pathobiochemistry of lysosomal (glyco-)sphingolipid storage diseases, structure and function of lysosomal enzymes and lipid binding proteins, topology of endocytosis and glycolipid metabolism, and regulation of glycolipid biosynthesis. He has published more than 480 peer-reviewed papers. Among many other prizes he also received the International Glycoconjugate Organization Award (2005).

Jiahua (Jay) Xie has completed his PhD in Biophysics at the age of 31 from Zhejiang University and postdoctoral studies from Departments of Genetics and Horticultural Science, North Carolina State University. He served as a Senior Scientist at the Vector Research Inc. (a subsidiary of Vector Group Ltd) for five years. Currently, he is an Associate Professor in the Department of Pharmaceutical Sciences and the PI of the BRITE, NCCU. He has published more than 50 papers in reputed journals and has been serving as an editorial board member of Journal of Zhejiang University (Agriculture and Life Sciences).

His research areas include Asialo-rhuEPO, a non-hematopoietic recombinant human erythropoietin (EPO) derivative lacking sialic acid, has been reported to display broad tissue-protective effects against damage triggered by ischemia/reperfusion, hypoxia or cytotoxic agents in the brain, the heart, the kidneys and the liver.

Dr Tony Velkov completed PhD in 2000 from Monash University. His anti-infective discovery research is at the leading edge globally. He was awarded a NHMRC Research Fellowships in 2006, 2011 and 2014. The quality and impact of his independent research was recognized by the NHMRC with an Excellence Award in 2011. He has published over 50 papers in high-caliber journals, 3 book chapters and 15 conference presentations. The dynamic team he leads consists of 3 postdocs, 3 RAs and 9 PhD students. Over the last 6 years, he has obtained >$9M funding from the NIH, NHMRC and foundations.

His research includes Influenza a constant global burden to human health.

Barbara Klajnert-Maculewicz has completed her Ph.D in 2002 from the University of Lodz, Poland and postdoctoral studies from the McMaster University, Ontario, Canada. She is a professor at the University of Lodz, Poland and an external scientific member at Leibniz IPF in Dresden, Germany. She is a co-author of 2 books and 9 chapters in monographs. She has published more than 90 papers in reputed journals (h-index 23). In the years 2009-2012 she was the Management Committee Chair of COST Action TD0802 “Dendrimers in biomedical applications” that gathered 24 countries. She has been awarded L’Oréal-UNESCO Fellowship for Women in Science.

Her research interests include Anticancer drugs such as cytarabine (araC) belong to nucleoside analogues (NAs). NAs are commonly used in the treatment of acute myeloid leukemia, acute lymphocytic leukemia, and lymphomas.

Dr. Wu obtained his Ph.D degree with W. Pigman, who is the pioneer in glycoproteins, at New York Medical College; and had his postdoctoral training at E.A. Kabat’s Lab for quantitative immunochemistry, Columbia University Medical Center, New York. He joined as a faculty position at Texas A&M University in 1982; promoted as a full professor at Chang-Gung University since 1989; and as Emeritus Professor in 2011. Dr. Wu published over 120 polyvalent glycotopes related papers. He is the chief editor for three volumes of Molecular Immunology of Complex Carbohydrates 1 to 3 in Adv. Exp. Med. Biol. 228, 451, 705 (Springer Publisher).

His major interests are (i) Glycan purification and characterization; (ii) recognition factors of glycans; (iii) combining sites of lectins and antibodies. He received many Outstanding Research Awards (1997-2008) from government agents in Taiwan.